Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 2200 of 3499 entries
View as:

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

Phase: N/A Priority: Normal
NCT ID: NCT04774289 Org: User:
Start: 02/24/21 End: 12/08/22 Due: 12/08/23

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00001238 Org: User:
Start: 12/05/90 End: - Due: -

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00474812 Org: User:
Start: 05/31/07 End: 02/28/14 Due: 02/28/15

Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00052559 Org: User:
Start: 08/31/02 End: - Due: -

Cause of Familial Testicular Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034424 Org: User:
Start: 01/13/03 End: - Due: -

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003288 Org: User:
Start: 08/31/98 End: - Due: -

Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00001450 Org: User:
Start: 09/30/95 End: 06/30/00 Due: 06/30/01

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02453620 Org: User:
Start: 02/12/16 End: 09/17/25 Due: 09/17/26

Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00281944 Org: User:
Start: 09/30/05 End: - Due: -

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Phase: N/A Priority: Normal
NCT ID: NCT01587352 Org: User:
Start: 05/29/12 End: 08/31/25 Due: 08/31/26

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06179888 Org: User:
Start: 08/27/24 End: 10/31/27 Due: 10/31/28

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00433576 Org: User:
Start: 12/31/06 End: 03/31/09 Due: 03/31/10

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00684983 Org: User:
Start: 07/30/08 End: 10/15/19 Due: 10/15/20

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Phase: N/A Priority: Normal
NCT ID: NCT06557733 Org: User:
Start: 05/28/25 End: 12/17/26 Due: 12/17/27

Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03701308 Org: User:
Start: 03/28/19 End: 12/01/25 Due: 12/01/26

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Phase: N/A Priority: Normal
NCT ID: NCT02390752 Org: User:
Start: 04/29/15 End: 12/01/25 Due: 12/01/26

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00118144 Org: User:
Start: 06/30/05 End: 12/31/10 Due: 12/31/11

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02359565 Org: User:
Start: 06/03/15 End: 12/21/25 Due: 12/21/26

A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers

Phase: N/A Priority: Normal
NCT ID: NCT00001699 Org: User:
Start: 06/30/98 End: 03/31/00 Due: 03/31/01

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00013533 Org: User:
Start: 03/14/01 End: 05/07/15 Due: 05/07/16

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03189108 Org: User:
Start: 05/22/17 End: 05/18/23 Due: 05/18/24

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01681368 Org: User:
Start: 08/15/12 End: 04/30/14 Due: 04/30/15

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04294628 Org: User:
Start: 09/01/20 End: 12/31/25 Due: 12/31/26

Esophageal Cancer Genetics Studies

Phase: N/A Priority: Normal
NCT ID: NCT00341276 Org: User:
Start: 07/06/95 End: 03/18/20 Due: 03/18/21

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01362803 Org: User:
Start: 09/21/11 End: 01/01/32 Due: 01/01/33